Krystal Biotech President Krishnan Suma sold 25,000 shares at prices ranging from $354.54 to $366.56 per share. The transaction matters to investors because Suma retained 1,302,145 Krystal Biotech shares after the sale, leaving a disclosed post-transaction ownership figure.

Key Highlights

  • Krishnan Suma completed the sale through 13 separate transactions.
  • The transactions took place on 4 September 2026.
  • Suma owned 1,302,145 Krystal Biotech shares after the transactions.

Regulatory Filing Krishnan Suma, President, R&D of Krystal Biotech, Inc.

(NASDAQ: KRYS) filed a Form 4 with the SEC. The filing concerns transactions in Krystal Biotech, Inc. shares and identifies the company as NASDAQ: KRYS.

Share Transactions On 4 September 2026, Suma sold a total of 25,000 Krystal Biotech, Inc.

shares across 13 separate transactions. All 13 transactions used SEC transaction code S, with prices ranging from $354.54 to $366.56 per share.

Reported Ownership Following

these transactions, Krishnan Suma owned 1,302,145 shares of Krystal Biotech, Inc. The filing identifies Suma as the company’s President, R&D and reports the post-transaction ownership figure after the 25,000-share sale.